The safety and efficacy of SGLT2 inhibitors

SLGT2 Inhibitors

Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.


Related Articles

17th April 2020

Diagnosing respiratory symptoms over the phone

We have another excellent blog from one of our tutors Andrew Booth, a Respiratory Nurse Specialist working in a GP...

Read More

4th November 2011

WHO dunnit?

Should the World Health Organisation be abolished ? The reason I ask this question is all to do with diabetes and...

Read More

11th March 2020

COVID-19 Update 17 March

We are closely monitoring the situation with COVID-19, and are following Public Health England’s guidance for...

Read More